Most successful businesses today were once penny stocks that few individuals trusted as worthy investments. Penny stocks typically don't attract much mainstream attention, because they're often extremely volatile and have lower liquidity than their large-cap counterparts. However, penny stocks have the potential to skyrocket once the underlying business gains traction and starts to thrive.
Here, we have two high-potential penny stocks that are clinical-stage biotech companies, Atossa Therapeutics (ATOS) and Ocugen (OCGN). Typically, biotech companies that treat rare and life-threatening diseases are always in demand.
